Long-Lasting Immune Response Induced by Recombinant Bacillus Calmette-Guérin (BCG) Secretion System

Scandinavian Journal of Immunology

Volumn 43, Issue 2, 1996, Pages 202-209

  Wada, N ^a   Ohara, N ^a   Kameoka, M ^b   Nishino, Y ^b   Matsumoto, S ^a   Nishiyama, T ^a   Naito, M ^a   Yukitake, H ^a   Okada, Y ^b   Ikuta, K ^b   Yamada, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MALE; MOUSE; MYCOBACTERIUM KANSASII; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BCG VACCINE; EPITOPES; GENE PRODUCTS, GAG; GENETIC VECTORS; HIV ANTIBODIES; HIV ANTIGENS; HIV-1; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; TIME FACTORS; VACCINES, SYNTHETIC; VIRAL PROTEINS;

EID: 0029671342     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-28.x     Document Type: Article

References (61)

1. Lamm DL. Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am 1992;19:573-80.
2. Morales A, Nickel JC. Immunotherapy for superficial bladder cancer. A development and clinical overview. Urol Clin North Am 1992;19:549-56.
3. Morton DL, Foshag LJ, Hoon DS et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann Surg 1992;216:463-82.
4. Jacobs WR Jr, Tuckman M, Bloom BR. Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature 1987; 327:532-5.
5. Snapper SB, Lugosi L, Jekkel A et al. Lysogeny and transformation in mycobacteria: stable expression of foreign genes. Proc Natl Acad Sci USA 1988;85:6987-91.
6. Ranes MG, Rauzier J, Lagranderie M, Gheorghiu M, Gicquel B. Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a 'mini' mycobacterium-Esherichia coli shuttle plasmid. J Bacteriol 1990;172:2793-7.
7. Snapper SB, Melton RE, Mustapha S, Kieser T, Jacobs WR Jr. Isolation and characterization of efficient plasmid transformation mutant of Mycobacterium smegmatis. Mol Microbiol 1990; 4:1911-19.
8. Husson RN, James BE, Young RA. Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 1990; 172:519-24.
9. Lee MH, Pascopella L, Jacobs WR Jr, Hatfull GF. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guérin. Proc Natl Acad Sci USA 1991;88: 3111-15.
10. Matsuo K, Yamaguchi R, Yamazaki A, Tasaka H, Terasaka K, Yamada T. Cloning and expression of the gene for the cross-reactive α antigen of Mycobacterium kansasii. Infect Immun 1990;58:550-6.
11. Matsuo K, Yamaguchi R, Yamazaki A et al. Establishment of a foreign antigen secretion system in mycobacteria. Infect Immun 1990;58:4049-54.
12. Stover CK, de la Cruz VF, Fuerst TR et al. New use of BCG for recombinant vaccines. Nature 1991;351:456-60.
13. Aldovini A, Young RA. Human and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 1991; 351:479-82.
14. Winter N, Lagranderie M, Rauzier J et al. Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 nef protein. Gene 1991;109:47-54.
15. Murray A, Winter N, Lagranderie M et al. Expression of Escherichia coli β-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses. Mol Microbiol 1992;6:3331-42.
16. Lagranderie M, Murray A, Gicquel B, Leclerc C, Gheorghiu M. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 1993;11:1283-90.
17. Kameoka M, Nishino Y, Matsuo K et al. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular α antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 1994;12:153-8.
18. Stover CK, Bansal GP, Hanson MS et al. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate lyme disease vaccine. J Exp Med 1993;178:197-209.
19. Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S. Systematic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 1994;372:552-5.
20. Langermann S, Palaszynski SR, Burlein JE et al. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J Exp Med 1994;180:2277-86.
21. Suzuki Y, Yoshinaga K, Ono Y, Nagata A, Yamada T. Organization of rRNA genes in Mycobacterium bovis BCG. J Bacteriol 1987;169:839-43.
22. Matsuo K, Yamaguchi R, Yamazaki A, Tasaka H, Yamada T. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular o antigen. J Bacteriol 1988;170:3847-54.
23. Ikuta K, Morita C, Ito S et al. Expression of human immunodeficiency virus type-1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens. Virology 1989;170:408-17.
24. Saitoh A, Tanaka N, Nakata A, Ikuta K, Shinagawa H. A unique monoclonal antibody that recognizes mature p17 of HIV-1 but not its precursor. Microbiol Immunol 1992;36:105-11.
25. Burlein JE, Stover CK, Offutt S, Hanson MS. Expression of foreign genes in mycobacteria. In: Bloom BR, ed. Tuberculosis: Pathogenesis, Protection, and Control. Washington DC: ASM Press, 1994:239-52.
26. Sarin PS, Sun DK, Thornton AH, Naylor PH, Goldstein AL. Neutralization of HTLV-III/LAV replication by antiserum to thymosin α1. Science 1986;232:1135-7.
27. Naylor PH, Naylor CW, Badamchian M et al. Human immunodeficiency virus contains an epitope immunoreactive with thymosin α1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30. Proc Natl Acad Sci USA 1987;84: 2951-5.
28. Coates ARM, Cookson J, Barton GJ, Zvelebil MJ, Sternberg MJE. AIDS vaccine predictions. Nature 1987;326:549-50.
29. Boucher CAB, Krone WJA, Goudsmit J et al. Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30. J Clin Lab Anal 1990;4:43-7.
30. Achour A, Picard O, Zagury D et al. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc Natl Acad Sci USA 1990;87:7045-9.
31. Naylor PH, Sztein MB, Wada S et al. Preclinical and clinical studies on immunogenicity and safety on the HIV-1 p17-based synthetic peptide AIDS vaccine-HGP-30-KLH. Int J Immunopharmac 1991;13:117-27.
32. Kahn JO, Stites DP, Scillian J et al. A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. AIDS Res Human Retroviruses 1992;8:1321-5.
33. Wiker HG, Harboe M, Nagai S, Patarroyo ME, Ramirez C, Cruz N. MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG. Int Arch Allergy Appl Immunol 1986;81:307-14.
34. Abou-Zeid C, Smith I, Grange JM, Ratliff TL, Steele J, Rook GAW. The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol 1988;134:531-8.
35. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991;59:1905-10.
36. Content J, de la Cuvellerie A, de Wit L, Vincent LFV, Ooms J, de Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 1991;59:3205-12.
37. Turneer M, van Vooren JP, de Bruyn J, Serruys E, Dierckx P, Yernault JC. Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified p32 protein antigen of Mycobacterium bovis bacillus Calmette-Guérin. J Clin Microbiol 1988;26:1714-9.
38. Abou-zeid C, Ratliff TL, Wiker HG, Harboe M, Bennedsen J, Rook GAW. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun 1988;56:3046-51.
39. Huygen K, Palfliet K, Jurion F et al. H-2 linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (p32) of Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun 1988;56:3196-200.
40. Thole JER, Schöningh R, Janson AAM et al. Molecular and immunological analysis of a fibronectin-binding protein antigen secreted by Mycobacterium leprae. Mol Microbiol 1992;6:153-63.
41. Wiker HG, Sletten K, Nagai S, Harboe M. Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect Immun 1990;58:272-4.
42. De Wit L, de la Cuvellerie A, Ooms J, Content J. Nucleotide sequence of the 32 kDa-protein gene (antigen 85A) of Mycobacterium bovis BCG. Nucl Acids Res 1990;18:3995.
43. Janicki BW, Chaparas SD, Daniel TM, Kubica GP, Wright GL, Yee GS. A reference system for antigens of Mycobacterium tuberculosis. Am Rev Respir Dis 1971;104:602-4.
44. Borremans M, de Wit L, Volckaert G et al. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect Immun 1989;57:3123-30.
45. Rinke de Wit TF, Bekelie S, Osland A, Wieles B, Janson AAM, Thole JER. The Mycobacterium leprae antigen 85 complex gene family: identification of the genes for the 85A, 85C, and related MPT51 proteins. Infect Immun 1993;61:3642-7.
46. Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun 1991;59:372-82.
47. Wiker HG, Nagai S, Harboe M, Ljungqvist L. A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand J Immunol 1992;36:307-19.
48. Ohara N, Kitaura H, Hotokezaka H et al. Characterization of the gene encoding the MPB51, one of the major secreted protein antigens of Mycobacterium bovis BCG, and identification of the secreted protein closely related to the fibronectin binding 85 complex. Scand J Immunol 1995;41:433-42.
49. Horwitz MA, Lee BWE, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995;92:1530-4.
50. Yamaguchi R, Matsuo K, Yamazaki A et al. Cloning and characterization of the gene for immunogenic protein MPB64 of Mycobacterium bovis BCG. Infect Immun 1989;57:283-8.
51. Terasaka K, Yamaguchi R, Matsuo K, Yamazaki A, Nagai S, Yamada T. Complete nucleotide sequence of immunogenic protein MPB70 from Mycobacterium bovis BCG. FEMS Microbiol Lett 1989;49:273-6.
52. Matsuo T, Matsumoto S, Ohara N, Kitaura H, Mizuno A, Yamada T. Differential transcription of the MPB70 genes in two major groups of Mycobacterium bovis BCG substrains. Microbiol 1995;141:1601-7.
53. Matsumoto S, Matsuo T, Ohara N et al. Cloning and sequencing of a unique antigen MPT70 from Mycobacterium tuberculosis H37Rv and expression in BCG using E. coli-Mycobacteria shuttle vector. Scand J Immunol 1995;41:281-7.
54. Yamaguchi R, Matsuo K, Yamazaki A, Nagai S, Terasaka K, Yamada T. Immunogenic protein MPB57 from Mycobacterium bovis BCG: molecular cloning, nucleotide sequence and expression. FEBS Lett 1988;240:115-7.
55. Yamaguchi R, Matsuo K, Yamazaki A, Kagawa H, Nagai S, Yamada T. Fusion protein based epitope mapping of the MPB57 protein from Mycobacterium bovis BCG and its epitope insertion into the native protein. Can J Microbiol 1991;37:7-13.
56. Ohara N, Kimura M, Wada N, Yamada T. Cloning and sequencing of the gene encoding the ribosomal L7/L12-like protein of Mycobacterium bovis BCG. Nucl Acids Res 1993;21:3579.
57. Tantimavanich S, Nagai S, Nomaguchi H, Kinomoto M, Ohara, N, Yamada T. Immunological properties of ribosomal proteins from Mycobacterium bovis BCG. Infect Immun 1993;61:4005-7.
58. Ohara N, Kimura M, Higashi Y, Yamada T. Isolation and amino acid sequence of the 30S ribosomal protein S19 from Mycobacterium bovis BCG. FEBS Lett 1993;331:9-14.
59. Ohara N, Matsuo K, Yamaguchi R, Yamazaki A, Tasaka H, Yamada T. Cloning and sequencing of the gene for a antigen from Mycobacterium avium and mapping of B cell epitopes. Infect Immun 1993;61:1173-9.
60. Kitaura H, Ohara N, Matsuo T, Tasaka H, Kobayashi K, Yamada T. Cloning, sequencing and expression of the gene for a antigen from Mycobacterium intracellulare and use of PCR for the rapid identification of Mycobacterium intracellulare. Biochem Biophys Res Commun 1993;196:1466-73.
61. Takano M, Ohara N, Mizuno A, Yamada T. Cloning, sequencing and expression in Escherichia coli of the gene for a antigen from Mycobacterium scrofulaceum. Scand J Immunol 1994;40: 165-70.